2024.Sep.23
Vaccine
What We Do
學術發表
2024.Aug.20
Technology
High-Efficiency Homogeneous ADC Platform by Endoglycosidase Sz Provides Insights into Its Transglycosylation Mechanism
2024.May.29
Vaccine
Positive associations of active immune therapy OBI-833/OBI-821 induced immune responses with clinical outcomes in patients with non-small cell lung cancer
2024.May.29
Others
Novel TROP2-targeted CAR T cells with high specificity and sustained efficacy for solid tumors in animal models
2024.May.04
Others
Clinical Characteristics and Mechanistic links of Tumor and Exosomal Globo H in Patients with Cholangiocarcinoma
2024.Apr.10
ADC
OBI-992, a novel TROP2 targeting antibody-drug conjugate, displayed excellent antitumor efficacy in various animal models
2024.Apr.10
ADC
OBI-992, a novel TROP2 targeting antibody drug conjugate demonstrates superior in vivo PK/PD properties and a favorable safety profile
2024.Apr.08
ADC